Societies and non-profits at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

6 societies and non-profits are at ACT 2026 — 10 presentations on the program. Most represented: HESI (4 on the program), Physicians Committee for Responsible Medicine (1 on the program), Henry M. Jackson Foundation (1 on the program). 4 of them have their own page in this guide. As of Oct 8, 2026.

All 231 organizations at ACT 2026 →

Showing 1–6 of 6 organizations

Organization	ACT 2026 Attendance
HESI Washington, DC	◇Silver Supporter
hesiglobal.org Societies and non-profitsSilver Supporter Non-profit running collaborative scientific programs among industry, government and academic scientists on human health and environmental safety questions.	Poster Mon Nov 16 5:00pm–6:30pm Expectations and Opinions on an ICH S7A Revision: Stakeholder Survey Results (P207) Nelson Exhibit Ballroom · Poster P207 Safety pharmacology · Regulatory Talk Wed Nov 18 9:00am–9:15am Part of The Future of Nonclinical Carcinogenicity Testing: NAMs in a Weight-of-Evidence Paradigm Shift (S15) From Rodent Bioassays to Mechanistic Evidence: The Future of Carcinogenicity Assessment (S15-1) Genetic toxicology Session Wed Nov 18 9:00am–12:00pm The Future of Nonclinical Carcinogenicity Testing: NAMs in a Weight-of-Evidence Paradigm Shift (S15) Genetic toxicology · New approach methods · with White Oak Regulatory Tox 9:00amFrom Rodent Bioassays to Mechanistic Evidence: The Future of Carcinogenicity Assessment (S15-1)HESI 9:15amCarcinogenicity Assessments Based on a Weight of Evidence Approach and the Role of NAMs in Supporting This Approach (S15-2)White Oak Regulatory Tox 9:45amIntegrating Error-Corrected Sequencing into OECD Test Guidelines: Advancing Precision Mutagenesis in Regulatory Toxicology (S15-3)Health Canada 10:45amAssessing Clonal Expansion of Cancer Driver Mutants as an Early Cancer Biomarker (S15-4)U.S. Food and Drug Administration 11:15amIndustry Perspectives on Advanced Methods for Carcinogenicity Risk Assessment (S15-5)GSK Talk Wed Nov 18 2:30pm–2:55pm Part of Hot Topics (S18) Benchmark Dose Modeling: Advancing Transparency and Next-Generation Applications in Risk Assessment (S18-3) In silico and AI · Chemical risk assessment Talk Wed Nov 18 2:55pm–3:15pm Part of Hot Topics (S18) Emerging Insights on QTc Risks in Targeted Protein Degraders (S18-4) Safety pharmacology
Physicians Committee for Responsible Medicine Washington, DC
pcrm.org Societies and non-profits Non-profit physicians' organization that promotes non-animal testing methods and human-relevant approaches in toxicology and research.	Talk Sun Nov 15 3:00pm–4:15pm Part of Quantitative Structure–Activity Relationship Demystified: Foundations, Best Practices, Regulatory Use, and Practical Applications (CE8) OECD QSAR Toolbox in Practice: Chemical Profiling, Category Formation, Read-Across, Data Gap Filling, and Interpretation (CE8-5) In silico and AI Talk Tue Nov 17 9:00am–9:05am Part of Next-Generation Liver Toxicity Assessment: Integrating Human-Relevant NAMs, AI, and Exposure Modeling (S07) Introduction (S07-1) New approach methods Session Tue Nov 17 9:00am–12:00pm Next-Generation Liver Toxicity Assessment: Integrating Human-Relevant NAMs, AI, and Exposure Modeling (S07) New approach methods · In silico and AI · with Boehringer Ingelheim 9:00amIntroduction (S07-1)Physicians Committee for Responsible Medicine 9:05amAn Integrated NAM Platform Combining Bioactivity Prediction with PBPK and Literature Intelligence for Chemical Liver Toxicity Assessment (S07-2)Human Chemical 9:30amMulticellular Hepatic In Vitro Models Using NANOSTACKS™: Flow-Driven Differential Toxicity and Human-Relevant Drug Response Prediction (S07-3)Revivocell 9:55amAI-Enabled, Exposure-Anchored DILI Prediction Using Human 3D Liver Microtissues (S07-4)InSphero 10:45amFrom Exposure Dynamics to Uncertainty: A Hybrid Framework for Drug-Induced Liver Injury Prediction (S07-5)ESQlabs 11:25amNovel Optical Techniques to Study Hepatic Microplastic Pollution: Optical Imaging as a Powerful New Approach Methodology (S07-6)University of New Mexico
Henry M. Jackson Foundation Bethesda, MD
hjf.org Societies and non-profits Non-profit that manages and supports military medical research; presents a web tool for analyzing toxicogenomic data.	Poster Mon Nov 16 5:00pm–6:30pm ToxMet: A Web Tool for the Analysis of Toxicogenomic Data Using Genome-Scale Metabolic Modeling (P529) Nelson Exhibit Ballroom · Poster P529 In silico and AI
IA International Academy of Toxicologic Pathology
Societies and non-profits International professional organization for toxicologic pathologists, promoting standards and education in the discipline.	Talk Mon Nov 16 9:15am–9:45am Part of Beyond the Vessel Wall: Translational Insights into Vascular Inflammation (S03) Drug Induced Vascular Injury (DIVI) Related to Biologic Therapies: Mechanisms and Sensitivity (S03-2) Pathology · Biologics and new modalities
Roundtable of Toxicology Consultants	◆Gold Supporter
toxconsultants.com Societies and non-profitsGold Supporter Professional association of independent toxicology consultants, whose member directory helps sponsors find and retain an expert.	Sponsor In the meeting’s sponsor directory, with no session on the public program
Society of Toxicology Reston, VA	◇Bronze Supporter
toxicology.org Societies and non-profitsBronze Supporter Professional society of about 8,000 toxicologists worldwide that holds an annual meeting and supports the field's science and careers.	Sponsor In the meeting’s sponsor directory, with no session on the public program

Instantly find 20 buyers from societies and non-profits

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction

Instantly find 20 buyers from societies and non-profits

Browse ACT 2026 by